MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079136 A) filed by Genome Therapeutics Ltd on June 26, 2026, for Tetracyclic Compounds For Use In Antibody-Drug Conjugates For The Treatment Of Cancer.
Inventors include Balasubramanian, Shankar; and Meo, Paul.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also relates to antibody- drug conjugates (ADCs) comprising the compounds, to processes for the preparation of the compounds and ADCs, as well as to ADCs and pharmaceutical compositions comprising them ...